Challenges in Tuberculosis Diagnosis and Management: Recommendations of the Expert Panel

Miliary tuberculosis leading to acute respiratory distress syndrome: Clinical experience in pediatric intensive care

“…All epidemiological, demographic, clinical, microbiological, and radiological data features were extracted from the institutional medical charts and digital medical reports. Diagnosis of miliary TB was based on the identification of the characteristic diffuse infiltrate on a chest radiograph or high‐resolution computerized tomographic (CT) scan and the presence of microbiological, cytopathological, histological, or molecular evidence of TB . Children with ARDS were therefore selected from the group of miliary TB patients.…”

“…Diagnosis of miliary TB was based on the identification of the characteristic diffuse infiltrate on a chest radiograph or high-resolution computerized tomographic (CT) scan and the presence of microbiological, cytopathological, histological, or molecular evidence of TB. [5][6][7] Children with ARDS were therefore selected from the group of miliary TB patients. Diagnosis of ARDS was established according to commonly shared definitions (American-European Consensus Conference, 8 Pediatric Acute Lung Injury Consensus Conference, 9 and the Berlin definition 10 ).…”

Topic Analysis and Mapping of Tuberculosis Research Using Text Mining and Co-Word Analysis

“…Since the diagnosis and treatment of tuberculosis has been among the main challenges of the health system for tuberculosis patients from the beginning, these results can be justified. Moreover, due to incorrect diagnosis and clinical similarities with some other diseases, as well as nonuse or misuse of antituberculosis drugs, drug resistance in this bacterium has occurred over time, this issue was one of the main challenges in the world in 2012, and many studies have been performed in this field [ 38 ]. Currently, the WHO is implementing detailed plans to cope with the problem of drug resistance in this bacterium at a global level.…”

Catalytic ferromagnetic gold nanoparticle immunoassay for the detection and differentiation of Mycobacterium tuberculosis and Mycobacterium bovis

“…Inaccurate diagnosis of ZTB compromises the efficacy of the treatment regime. This increases the risk of disease transmission and potentially contributes to the development of antibiotic-resistant TB, resulting in increased patient morbidities and mortalities [13]. Differential diagnosis of the causative agent of TB infection is therefore a crucial part of effective disease control plans to: (i) effectively direct chemotherapy; (ii) facilitate the study of the transmission of mycobacteria between humans and animals; and (iii) provide more accurate estimations of the scale of ZTB.…”